• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过基于细胞的模型对他莫昔芬敏感性进行综合“组学”分析。

Integrative "omic" analysis for tamoxifen sensitivity through cell based models.

作者信息

Weng Liming, Ziliak Dana, Lacroix Bonnie, Geeleher Paul, Huang R Stephanie

机构信息

Section of Hematology and Oncology, Department of Medicine, University of Chicago, Chicago, Illinois, United States of America.

出版信息

PLoS One. 2014 Apr 3;9(4):e93420. doi: 10.1371/journal.pone.0093420. eCollection 2014.

DOI:10.1371/journal.pone.0093420
PMID:24699530
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3974759/
Abstract

It has long been observed that tamoxifen sensitivity varies among breast cancer patients. Further, ethnic differences of tamoxifen therapy between Caucasian and African American have also been reported. Since most studies have been focused on Caucasian people, we sought to comprehensively evaluate genetic variants related to tamoxifen therapy in African-derived samples. An integrative "omic" approach developed by our group was used to investigate relationships among endoxifen (an active metabolite of tamoxifen) sensitivity, SNP genotype, mRNA and microRNA expressions in 58 HapMap YRI lymphoblastoid cell lines. We identified 50 SNPs that associate with cellular sensitivity to endoxifen through their effects on 34 genes and 30 microRNA expression. Some of these findings are shared in both Caucasian and African samples, while others are unique in the African samples. Among gene/microRNA that were identified in both ethnic groups, the expression of TRAF1 is also correlated with tamoxifen sensitivity in a collection of 44 breast cancer cell lines. Further, knock-down TRAF1 and over-expression of hsa-let-7i confirmed the roles of hsa-let-7i and TRAF1 in increasing tamoxifen sensitivity in the ZR-75-1 breast cancer cell line. Our integrative omic analysis facilitated the discovery of pharmacogenomic biomarkers that potentially affect tamoxifen sensitivity.

摘要

长期以来人们观察到,乳腺癌患者对他莫昔芬的敏感性存在差异。此外,也有报道称白种人和非裔美国人在他莫昔芬治疗方面存在种族差异。由于大多数研究都集中在白种人身上,我们试图全面评估非洲裔样本中与他莫昔芬治疗相关的基因变异。我们团队开发的一种综合“组学”方法用于研究58个HapMap YRI淋巴母细胞系中内昔芬(他莫昔芬的活性代谢物)敏感性、单核苷酸多态性(SNP)基因型、mRNA和微小RNA表达之间的关系。我们通过对34个基因和30个微小RNA表达的影响,鉴定出50个与细胞对内昔芬敏感性相关的SNP。其中一些发现白种人和非洲裔样本中都有,而其他一些则是非洲裔样本所特有的。在两个种族群体中都鉴定出的基因/微小RNA中,TRAF1的表达在44个乳腺癌细胞系中也与他莫昔芬敏感性相关。此外,敲低TRAF1和过表达hsa-let-7i证实了hsa-let-7i和TRAF1在增加ZR-75-1乳腺癌细胞系对他莫昔芬敏感性方面的作用。我们的综合组学分析有助于发现可能影响他莫昔芬敏感性的药物基因组生物标志物。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2fe9/3974759/85172f23c99b/pone.0093420.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2fe9/3974759/85172f23c99b/pone.0093420.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2fe9/3974759/85172f23c99b/pone.0093420.g002.jpg

相似文献

1
Integrative "omic" analysis for tamoxifen sensitivity through cell based models.通过基于细胞的模型对他莫昔芬敏感性进行综合“组学”分析。
PLoS One. 2014 Apr 3;9(4):e93420. doi: 10.1371/journal.pone.0093420. eCollection 2014.
2
Genome-wide discovery of genetic variants affecting tamoxifen sensitivity and their clinical and functional validation.全基因组发现影响他莫昔芬敏感性的遗传变异及其临床和功能验证。
Ann Oncol. 2013 Jul;24(7):1867-1873. doi: 10.1093/annonc/mdt125. Epub 2013 Mar 18.
3
let-7 microRNAs induce tamoxifen sensitivity by downregulation of estrogen receptor α signaling in breast cancer.let-7 微 RNA 通过下调乳腺癌中雌激素受体 α 信号诱导他莫昔芬敏感性。
Mol Med. 2011;17(11-12):1233-41. doi: 10.2119/molmed.2010.00225. Epub 2011 Jul 27.
4
A polymorphism in the TC21 promoter associates with an unfavorable tamoxifen treatment outcome in breast cancer.TC21启动子中的一种多态性与乳腺癌患者他莫昔芬治疗效果不佳相关。
Cancer Res. 2008 Dec 1;68(23):9799-808. doi: 10.1158/0008-5472.CAN-08-0247.
5
Population differences in microRNA expression and biological implications.人群中 microRNA 表达的差异及其生物学意义。
RNA Biol. 2011 Jul-Aug;8(4):692-701. doi: 10.4161/rna.8.4.16029. Epub 2011 Jul 1.
6
4-Hydroxytamoxifen enhances sensitivity of estrogen receptor α-positive breast cancer to docetaxel in an estrogen and ZNF423 SNP-dependent fashion.4-羟基他莫昔芬以雌激素和 ZNF423 SNP 依赖性方式增强雌激素受体 α 阳性乳腺癌对多西紫杉醇的敏感性。
Breast Cancer Res Treat. 2019 Jun;175(3):567-578. doi: 10.1007/s10549-019-05194-z. Epub 2019 Apr 1.
7
Simulation with cells in vitro of tamoxifen treatment in premenopausal breast cancer patients with different CYP2D6 genotypes.对不同CYP2D6基因型的绝经前乳腺癌患者进行他莫昔芬治疗的体外细胞模拟。
Br J Pharmacol. 2014 Dec;171(24):5624-35. doi: 10.1111/bph.12864.
8
circRNA_0025202 Regulates Tamoxifen Sensitivity and Tumor Progression via Regulating the miR-182-5p/FOXO3a Axis in Breast Cancer.环状 RNA_0025202 通过调控 miR-182-5p/FOXO3a 轴调控乳腺癌他莫昔芬敏感性和肿瘤进展。
Mol Ther. 2019 Sep 4;27(9):1638-1652. doi: 10.1016/j.ymthe.2019.05.011. Epub 2019 May 17.
9
Endoxifen (4-hydroxy-N-desmethyl-tamoxifen) has anti-estrogenic effects in breast cancer cells with potency similar to 4-hydroxy-tamoxifen.依西美坦(4-羟基-N-去甲基他莫昔芬)在乳腺癌细胞中具有抗雌激素作用,其效力与4-羟基他莫昔芬相似。
Cancer Chemother Pharmacol. 2005 May;55(5):471-8. doi: 10.1007/s00280-004-0926-7. Epub 2005 Feb 1.
10
SNPs near the cysteine proteinase cathepsin O gene (CTSO) determine tamoxifen sensitivity in ERα-positive breast cancer through regulation of BRCA1.半胱氨酸蛋白酶组织蛋白酶O基因(CTSO)附近的单核苷酸多态性通过调控BRCA1来决定雌激素受体α阳性乳腺癌中他莫昔芬的敏感性。
PLoS Genet. 2017 Oct 2;13(10):e1007031. doi: 10.1371/journal.pgen.1007031. eCollection 2017 Oct.

引用本文的文献

1
Functional analysis of the effects of propofol on tamoxifen‑resistant breast cancer cells: Insights into transcriptional regulation.丙泊酚对他莫昔芬耐药乳腺癌细胞作用的功能分析:转录调控的见解
Oncol Lett. 2025 Feb 21;29(4):194. doi: 10.3892/ol.2025.14940. eCollection 2025 Apr.
2
Quantitative Framework for Bench-to-Bedside Cancer Research.从实验室到临床的癌症研究定量框架
Cancers (Basel). 2022 Oct 26;14(21):5254. doi: 10.3390/cancers14215254.
3
Differential miRNA Expression in Human Macrophage-Like Cells Infected with Yeasts Cultured in Planktonic and Biofilm Forms.

本文引用的文献

1
Integrative genomics: quantifying significance of phenotype-genotype relationships from multiple sources of high-throughput data.整合基因组学:从多种高通量数据来源量化表型-基因型关系的意义。
Front Genet. 2013 May 31;3:202. doi: 10.3389/fgene.2012.00202. eCollection 2012.
2
Toxicity and adverse effects of Tamoxifen and other anti-estrogen drugs.他莫昔芬和其他抗雌激素药物的毒性和不良反应。
Pharmacol Ther. 2013 Sep;139(3):392-404. doi: 10.1016/j.pharmthera.2013.05.005. Epub 2013 May 24.
3
Genome-wide discovery of genetic variants affecting tamoxifen sensitivity and their clinical and functional validation.
浮游和生物膜形式培养的酵母感染的人巨噬细胞样细胞中miRNA的差异表达
J Fungi (Basel). 2021 Jan 18;7(1):60. doi: 10.3390/jof7010060.
4
MicroRNAs and Their Impact on Breast Cancer, the Tumor Microenvironment, and Disparities.微小RNA及其对乳腺癌、肿瘤微环境和差异的影响。
Adv Cancer Res. 2017;133:51-76. doi: 10.1016/bs.acr.2016.08.003. Epub 2016 Sep 26.
5
Roles for miRNAs in endocrine resistance in breast cancer.微小RNA在乳腺癌内分泌抵抗中的作用。
Endocr Relat Cancer. 2015 Oct;22(5):R279-300. doi: 10.1530/ERC-15-0355.
全基因组发现影响他莫昔芬敏感性的遗传变异及其临床和功能验证。
Ann Oncol. 2013 Jul;24(7):1867-1873. doi: 10.1093/annonc/mdt125. Epub 2013 Mar 18.
4
Genetic architecture of microRNA expression: implications for the transcriptome and complex traits.miRNA 表达的遗传结构:对转录组和复杂性状的影响。
Am J Hum Genet. 2012 Jun 8;90(6):1046-63. doi: 10.1016/j.ajhg.2012.04.023. Epub 2012 May 31.
5
Histone ubiquitination and deubiquitination in transcription, DNA damage response, and cancer.组蛋白泛素化和去泛素化在转录、DNA 损伤反应和癌症中的作用。
Front Oncol. 2012 Mar 12;2:26. doi: 10.3389/fonc.2012.00026. eCollection 2012.
6
Subtype and pathway specific responses to anticancer compounds in breast cancer.乳腺癌中抗癌化合物的亚型和途径特异性反应。
Proc Natl Acad Sci U S A. 2012 Feb 21;109(8):2724-9. doi: 10.1073/pnas.1018854108. Epub 2011 Oct 14.
7
let-7 microRNAs induce tamoxifen sensitivity by downregulation of estrogen receptor α signaling in breast cancer.let-7 微 RNA 通过下调乳腺癌中雌激素受体 α 信号诱导他莫昔芬敏感性。
Mol Med. 2011;17(11-12):1233-41. doi: 10.2119/molmed.2010.00225. Epub 2011 Jul 27.
8
Platinum sensitivity-related germline polymorphism discovered via a cell-based approach and analysis of its association with outcome in ovarian cancer patients.基于细胞的方法发现铂类药物敏感性相关种系多态性及其与卵巢癌患者结局的相关性分析。
Clin Cancer Res. 2011 Aug 15;17(16):5490-500. doi: 10.1158/1078-0432.CCR-11-0724. Epub 2011 Jun 24.
9
Germline polymorphisms discovered via a cell-based, genome-wide approach predict platinum response in head and neck cancers.基于细胞的全基因组方法发现的种系多态性可预测头颈部癌症对铂类的反应。
Transl Res. 2011 May;157(5):265-72. doi: 10.1016/j.trsl.2011.01.005. Epub 2011 Feb 8.
10
Pharmacogenomic discovery using cell-based models.基于细胞模型的药物基因组学发现。
Pharmacol Rev. 2009 Dec;61(4):413-29. doi: 10.1124/pr.109.001461.